| 000 | 01832 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517122556.0 | ||
| 264 | 0 | _c20170529 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/s12879-016-1905-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAuld, Andrew F | |
| 245 | 0 | 0 |
_aImplementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _cOct 2016 |
||
| 300 |
_a606 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAmbulatory Care Facilities |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBotswana |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicroscopy |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRadiography, Thoracic |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aSputum _xmicrobiology |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdiagnosis |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
| 700 | 1 | _aAgizew, Tefera | |
| 700 | 1 | _aPals, Sherri | |
| 700 | 1 | _aFinlay, Alyssa | |
| 700 | 1 | _aNdwapi, Ndwapi | |
| 700 | 1 | _aBoyd, Rosanna | |
| 700 | 1 | _aAlexander, Heather | |
| 700 | 1 | _aMathoma, Anikie | |
| 700 | 1 | _aBasotli, Joyce | |
| 700 | 1 | _aGwebe-Nyirenda, Sambayawo | |
| 700 | 1 | _aShepherd, James | |
| 700 | 1 | _aEllerbrock, Tedd V | |
| 700 | 1 | _aDate, Anand | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 16 _gno. 1 _gp. 606 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12879-016-1905-4 _zAvailable from publisher's website |
| 999 |
_c26551032 _d26551032 |
||